Breast Cancer - Anti-Progestin Prevention Study 1
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: ulipristal acetate
Sponsor: Manchester University NHS Foundation Trust
Collaborators: University of Manchester